Opioid Overdose Reversal Guidelines

Initial Dosing and Administration

The American Heart Association recommends an initial dose of naloxone for opioid overdose reversal of 0.4-2 mg intravenously, which may be repeated every 2-3 minutes until respiratory function improves, with consideration for lower doses (0.04-0.4 mg) in opioid-dependent patients to minimize withdrawal symptoms 1, 2
For children, the initial dose is 0.01 mg/kg body weight; it may be increased to 0.1 mg/kg if needed, as recommended by the American Academy of Pediatrics 3
Intranasal administration of naloxone is recommended at a dose of 2 mg, which may be repeated in 3-5 minutes if necessary 1, 4
Nebulized naloxone can be administered at a dose of 2 mg diluted in 3 mL normal saline 1
Intravenous administration provides the fastest onset of action, typically within 1-2 minutes, according to the American Gastroenterological Association 5

The American Heart Association suggests focusing on supporting airway and breathing before naloxone administration, with an emphasis on assessing airway and breathing first 6, 7
Rescue breathing should be initiated if necessary, and naloxone administration should be based on the clinical scenario, such as respiratory arrest with pulse or cardiac arrest 6
Assessing responsiveness and breathing, beginning rescue breathing if necessary, administering naloxone, reassessing after 2-3 minutes, and repeating the dose if there is an inadequate response is the recommended treatment protocol, as outlined by the American Heart Association and the American Academy of Pediatrics 5, 4, 3

Repeated doses of naloxone may be required, or a continuous infusion may be necessary, with careful titration to restore adequate respiration without precipitating severe withdrawal 6
Patients should be observed for at least 2 hours after the last dose of naloxone, with monitoring for recurrent respiratory depression due to naloxone's shorter duration of action compared to many opioids 6, 2, 3
The onset of action of naloxone is 1-2 minutes after intravenous administration, with a peak effect at 3-4 minutes, and a duration of action of 30-45 minutes, which is shorter than many opioids, necessitating repeated doses for long-acting opioids, as reported by the American Gastroenterological Association and the American Medical Association 5, 4

Administering excessive doses of naloxone to opioid-dependent patients can precipitate severe withdrawal symptoms, such as hypertension, tachycardia, vomiting, and agitation 1, 4
Relying solely on naloxone in cardiac arrest is not recommended, as high-quality CPR should take priority over naloxone administration 6
Delayed emergency response activation can be harmful, as rescuers should not delay activating emergency services while awaiting response to naloxone 6
Premature discontinuation of monitoring can lead to patients developing recurrent respiratory depression, as the duration of action of naloxone is shorter than many opioids 6

Proper medication storage out of children's reach, use of child-resistant containers, and parent education about medication safety are crucial to prevent medication overdose in children, as recommended by the American Academy of Pediatrics 3
Parent education about medication safety and proper storage is crucial to prevent medication overdose in children, as recommended by the American Academy of Pediatrics 3

Naloxone is a competitive opioid receptor antagonist that reverses opioid overdose by antagonizing mu, kappa, and delta opioid receptors, competing with and displacing opioids at receptor sites, and reversing respiratory depression, sedation, and hypotension caused by opioids, as stated by the American Medical Association and the American Gastroenterological Association 5, 4